6.
Wolff E, Lee S, Park M
. Assay of deoxyhypusine synthase activity. Methods Mol Biol. 2011; 720:195-205.
PMC: 3178833.
DOI: 10.1007/978-1-61779-034-8_12.
View
7.
Pelechano V, Alepuz P
. eIF5A facilitates translation termination globally and promotes the elongation of many non polyproline-specific tripeptide sequences. Nucleic Acids Res. 2017; 45(12):7326-7338.
PMC: 5499558.
DOI: 10.1093/nar/gkx479.
View
8.
Wolff E, Wolff J, Park M
. Deoxyhypusine synthase generates and uses bound NADH in a transient hydride transfer mechanism. J Biol Chem. 2000; 275(13):9170-7.
DOI: 10.1074/jbc.275.13.9170.
View
9.
DAgostino M, Simonetti A, Motta S, Wolff P, Romagnoli A, Piccinini A
. Crystal structure of archaeal IF5A-DHS complex reveals insights into the hypusination mechanism. Structure. 2024; 32(7):878-888.e4.
DOI: 10.1016/j.str.2024.03.008.
View
10.
Kaiser A, Agostinelli E
. Hypusinated EIF5A as a feasible drug target for Advanced Medicinal Therapies in the treatment of pathogenic parasites and therapy-resistant tumors. Amino Acids. 2022; 54(4):501-511.
DOI: 10.1007/s00726-021-03120-6.
View
11.
Liu K, Li X, Wang D, Xue W, Qian X, Li Y
. Novel Allosteric Inhibitors of Deoxyhypusine Synthase against Malignant Melanoma: Design, Synthesis, and Biological Evaluation. J Med Chem. 2021; 64(18):13356-13372.
DOI: 10.1021/acs.jmedchem.1c00582.
View
12.
Lemay S, Grobs Y, Romanet C, Martineau S, Salem M, Shimauchi T
. Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2024; 209(11):1376-1391.
DOI: 10.1164/rccm.202305-0909OC.
View
13.
Lee Y, Folk J
. Branched-chain and unsaturated 1,7-diaminoheptane derivatives as deoxyhypusine synthase inhibitors. Bioorg Med Chem. 1998; 6(3):253-70.
DOI: 10.1016/s0968-0896(97)10030-x.
View
14.
Nishimura K, Ohki Y, Fukuchi-Shimogori T, Sakata K, Saiga K, Beppu T
. Inhibition of cell growth through inactivation of eukaryotic translation initiation factor 5A (eIF5A) by deoxyspergualin. Biochem J. 2002; 363(Pt 3):761-8.
PMC: 1222529.
DOI: 10.1042/0264-6021:3630761.
View
15.
Tauc M, Cougnon M, Carcy R, Melis N, Hauet T, Pellerin L
. The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles. Cell Biosci. 2021; 11(1):219.
PMC: 8705083.
DOI: 10.1186/s13578-021-00733-y.
View
16.
Wu G, Xu Y, Lau A
. Recent insights into eukaryotic translation initiation factors 5A1 and 5A2 and their roles in human health and disease. Cancer Cell Int. 2020; 20:142.
PMC: 7191727.
DOI: 10.1186/s12935-020-01226-7.
View
17.
Eberhard Y, McDermott S, Wang X, Gronda M, Venugopal A, Wood T
. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells. Blood. 2009; 114(14):3064-73.
DOI: 10.1182/blood-2009-03-209965.
View
18.
Libby P, Henderson M, Bergeron R, Porter C
. Major increases in spermidine/spermine-N1-acetyltransferase activity by spermine analogues and their relationship to polyamine depletion and growth inhibition in L1210 cells. Cancer Res. 1989; 49(22):6226-31.
View
19.
Ofek P, Yeini E, Arad G, Danilevsky A, Pozzi S, Luna C
. Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma. Int J Cancer. 2023; 153(3):654-668.
DOI: 10.1002/ijc.34545.
View
20.
Park M, Wolff E, Lee Y, Folk J
. Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines. J Biol Chem. 1994; 269(45):27827-32.
View